Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Migraine Disorders: HELP
Marcelo Eduardo Bigal
Based on 113 articles published since 2008
||||
Expertise Level
The expertise of Marcelo Eduardo Bigal ranks in the
  • Top 0.028%
  • ... of 21,348 published authors worldwide on Migraine Disorders
  • ... from 2008 through 2018
  • ... based on contributions to 113 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Bigal, Marcelo E   ·   Bigal, M   ·   Bigal, Marcelo Eduardo   ·   Bigal, Marcelo   ·   Bigal, M E
Work Locations
Details
Most likely:    Miscellaneous cities in Pennsylvania      
2018
  • Mayo Clinic Arizona, Phoenix. · Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Teva Pharmaceuticals, Frazer, Pennsylvania. · NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, London, England. · Pubmed 29800211
2017
  • Medical Affairs, Teva Pharmaceutical Industries, Frazer, PA, USA. · Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. · Biostatistics, Teva Pharmaceutical Industries, Frazer, PA, USA. · Department of Neurology, New York University Medical Center, New York, NY, USA. · Clinical Development, Teva Pharmaceutical Industries, Frazer, PA, USA. · Pubmed 28862758
  • Department of Biomechanics, Medicine, and Locomotor Apparatus Rehabilitation, Ribeirão Preto Medicine School, University of São Paulo, Ribeirão Preto-SP, Brazil. Electronic address: · Department of Biomechanics, Medicine, and Locomotor Apparatus Rehabilitation, Ribeirão Preto Medicine School, University of São Paulo, Ribeirão Preto-SP, Brazil. · Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medicine School, University of São Paulo, Ribeirão Preto-SP, Brazil. · Migraine & Headache Clinical Development, Global Branded R&D, Frazer, Pennsylvania. · Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, Alcorcón, Spain. · Pubmed 28390711
  • Albert Einstein Hospital, R Joaquim Eugenio de Lima, 881 cj 709, 01403-001, São Paulo, SP, Brazil. · Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Albert Einstein Hospital, R Joaquim Eugenio de Lima, 881 cj 709, 01403-001, São Paulo, SP, Brazil. · Natura, São Paulo, Brazil. · Teva Pharmaceuticals, North Wales, PA, USA. · Pubmed 28324317
  • Department of Biomechanics, Medicine and Locomotor Apparatus Rehabilitation - Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto-SP, Brazil. · Department of Physical Medicine and Rehabilitation, Harvard Medical School, Charlestown, MA, USA. · Department of Neurosciences and Behavioral Sciences - Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto-SP, Brazil. · Research and Development Department, Teva Pharmaceuticals, Frazer, PA, USA. · Pubmed 27991667
  • Department of Dental Materials and Prosthodontics/Araraquara School of Dentistry, University Estadual Paulista - UNESP, Araraquara, Brazil. · Department of Oral Kinesiology, Academic Centre for Dentistry Amsterdam (ACTA), MOVE Research Institute Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands. · Global Clinical Development - Migraine and Headaches, Teva Pharmaceuticals, Frazer, PA, USA. · Pubmed 27748537
2016
  • Research and Development, Teva Pharmaceutical Industries, Netanya, Israel. · Research and Development, Teva Pharmaceutical Industries, West Chester, PA, USA. · Clinical Development, Teva Pharmaceutical Industries, Frazer, PA, USA. · Children's Health Center, Duke University Medical Center, Durham, NC, USA. · Patient Safety & Pharmacovigilance, Teva Pharmaceutical Industries, Petach Tikva, Israel. · Dallas Pediatric Neurology Associates, Dallas, TX, USA. · NuPathe Inc, Conshohocken, PA, USA. · Palm Beach Neurology - Premiere Research Institute, West Palm Beach, FL, USA. · Research and Development, Teva Pharmaceutical Industries, Netanya, Israel. · Pubmed 27474357
  • Ribeirao Preto Medical School, Department of Biomechanics, Medicine and Locomotor Aparattus Rehabilitation, University of São Paulo, Ribeirao Preto, SP, Brazil. Electronic address: · Physiotherapy School, University of Maranhao Center, Sao Luis, MA, Brazil. · Ribeirao Preto Medical School, Department of Biomechanics, Medicine and Locomotor Aparattus Rehabilitation, University of São Paulo, Ribeirao Preto, SP, Brazil. · Ribeirao Preto Medical School, Department of Neuroscience and Behavioral Sciences, University of São Paulo, Ribeirao Preto, SP, Brazil. · Global Clinical Development, Teva Pharmaceutical Industries, Frazer, PA. · Pubmed 26718237
2015
  • Vice President, Migraine & Headache Clinical Development, Teva Pharmaceuticals, Frazer, PA. · Department of Neurology, Albert Einstein College of Medicine, Bronx, NY. · Director of Preclinical Research, Labrys Biologics, Inc, San Mateo, CA. · Director-Emeritus, New England Center for Headache, Stamford, CT. · Clinical Professor of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Pubmed 25614243
  • Research and Development Department, Teva Pharmaceuticals, Frazer, PA, USA. Electronic address: · Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. · The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Neurology, Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA. · Statistics Department, Teva Pharmaceuticals, Frazer, PA, USA. · Research and Scientific Affairs Department, Teva Pharmaceuticals, Frazer, PA, USA. · Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Headache Institute and St Luke's-Roosevelt Hospital Center, New York, NY, USA. · Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA. · Pubmed 26432182
  • Research and Development Department, Teva Pharmaceuticals, Frazer, PA, USA. Electronic address: · Department of Internal Medicine, Lund University Hospital, Lund, Sweden. · The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA. · Clinical Research, MedVadis Research, Boston, MA, USA. · Department of Neurology, Essen Headache Center, Essen, Germany. · Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Research and Scientific Affairs Department, Teva Pharmaceuticals, Frazer, PA, USA. · Statistics Department, Teva Pharmaceuticals, Frazer, PA, USA. · Department of Neurology, Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA. · Pubmed 26432181
  • Department of Biomechanics, Medicine and Locomotor Apparatus Rehabilitation - Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil. · Department of Neurosciences and Behavioral Sciences - Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil. · Migraine & Headache Clinical Development, Global Branded R&D, Frazer, PA, USA. · Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, Alcorcón, Spain. · Pubmed 26388193
  • Migraine and Headache Clinical Development, Teva Pharmaceuticals, Frazer, PA, USA. · Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA. · Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. · Headache Institute, St. Luke's-Roosevelt Hospital Center, New York, NY, USA. · NuPathe Inc., Conshohocken, PA, USA. · Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Jefferson Hospital for Neuroscience, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Pubmed 26178815
2014
2012
  • Head of the Merck Investigator Study Program, Scientific Engagement and Education, Office of the Chief Medical Officer-Merck, North Wales, PA, USA. · Pubmed 22573400
2011
  • Office of the Chief Medical Officer, Merck & Co., Inc, North Wales, PA 19454, USA. · Pubmed 21755137
  • Head of the Merck Investigator Studies Program, Scientific Education Group, Office of the Chief Medical Officer, Merck Inc., Upper Gwynedd, PA, USA. · Pubmed 21359435
  • Head of the Merck Investigator Study Program and Scientific Education Group, Office of the Chief Medical Officer, Merck & Co., Inc., 351 North Sumneytown Pike, North Wales, PA 19454, USA. · Pubmed 21243447
2010
  • Office of the Chief Medical Officer-Merck inc. Upper Gwynedd, PA, USA. · Pubmed 20572878
  • Office of the Chief Medical Officer, Merck, 351 North Sumneytown Pike, Upper Gwynedd, PA 19454, USA. · Pubmed 20533956
  • Merck Inc., Upper Gwynedd, PA 19454, USA. · Pubmed 20490743
2015
  • Migraine & Headache, Clinical Development, Global Branded R&D, Teva Pharmaceuticals, 41 Moores Road, Frazer, PA, 19355, USA. · Pubmed 25754596
2011
  • Epidemiology Department, Merck Sharp & Dohme Corp., North Wales, PA 19454, USA. · Pubmed 21198571
2009
  • Epidemiology Department, Merck Research Laboratories, 351 North Sumneytown Pike, North Wales, PA, USA. · Pubmed 19456878
  • Merck Research Laboratories, North Wales, PA 19454-1099, USA. · Pubmed 19222588
Probable:    Miscellaneous cities in Wales      
2017
  • Albert Einstein Hospital, R Joaquim Eugenio de Lima, 881 cj 709, 01403-001, São Paulo, SP, Brazil. · Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Albert Einstein Hospital, R Joaquim Eugenio de Lima, 881 cj 709, 01403-001, São Paulo, SP, Brazil. · Natura, São Paulo, Brazil. · Teva Pharmaceuticals, North Wales, PA, USA. · Pubmed 28324317
2012
  • Head of the Merck Investigator Study Program, Scientific Engagement and Education, Office of the Chief Medical Officer-Merck, North Wales, PA, USA. · Pubmed 22573400
2011
  • Office of the Chief Medical Officer, Merck & Co., Inc, North Wales, PA 19454, USA. · Pubmed 21755137
  • Head of the Merck Investigator Study Program and Scientific Education Group, Office of the Chief Medical Officer, Merck & Co., Inc., 351 North Sumneytown Pike, North Wales, PA 19454, USA. · Pubmed 21243447
2011
  • Epidemiology Department, Merck Sharp & Dohme Corp., North Wales, PA 19454, USA. · Pubmed 21198571
2009
  • Epidemiology Department, Merck Research Laboratories, 351 North Sumneytown Pike, North Wales, PA, USA. · Pubmed 19456878
  • Merck Research Laboratories, North Wales, PA 19454-1099, USA. · Pubmed 19222588
Probable:    Thomas Jefferson University   Contact    
2017
  • From the Jefferson Headache Center, Thomas Jefferson University, Philadelphia (S.D.S.), and Teva Pharmaceuticals, Frazer (M.E.B., P.P.Y., T.B., M.G.-W., R.Y., Y.M., E.A.) - both in Pennsylvania · Mayo Clinic Arizona, Phoenix (D.W.D.) · and National Institute for Health Research-Wellcome Trust King's Clinical Research Facility, King's College London, London (P.J.G.). · Pubmed 29171818
2009
  • Thomas Jefferson University, Department of Neurology, Philadelphia, PA 19107, USA. · Pubmed 19719543
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 113 total) written by Marcelo Eduardo Bigal about Migraine Disorders:

  • Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial. 2018
  • Fremanezumab for the Preventive Treatment of Chronic Migraine. 2017
  • Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines. 2017
  • Association Between Severity of Temporomandibular Disorders and the Frequency of Headache Attacks in Women With Migraine: A Cross-Sectional Study. 2017
  • Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease. 2017
  • Anxiety and depression symptoms and migraine: a symptom-based approach research. 2017
  • Balance Impairments in Different Subgroups of Patients With Migraine. 2017
  • Obesity as a risk factor for temporomandibular disorders. 2017
  • A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients. 2016
  • TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points. 2016
Show List of Full Article Records
Google Searches

Learn more about Marcelo Eduardo Bigal using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous cities in Pennsylvania
Miscellaneous cities in Wales
Thomas Jefferson University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous cities in Pennsylvania
2018
  • Mayo Clinic Arizona, Phoenix. · Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Teva Pharmaceuticals, Frazer, Pennsylvania. · NIHR-Wellcome Trust King's Clinical Research Facility, King's College London, London, England. · Pubmed 29800211
2017
  • Medical Affairs, Teva Pharmaceutical Industries, Frazer, PA, USA. · Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. · Biostatistics, Teva Pharmaceutical Industries, Frazer, PA, USA. · Department of Neurology, New York University Medical Center, New York, NY, USA. · Clinical Development, Teva Pharmaceutical Industries, Frazer, PA, USA. · Pubmed 28862758
  • Department of Biomechanics, Medicine, and Locomotor Apparatus Rehabilitation, Ribeirão Preto Medicine School, University of São Paulo, Ribeirão Preto-SP, Brazil. Electronic address: · Department of Biomechanics, Medicine, and Locomotor Apparatus Rehabilitation, Ribeirão Preto Medicine School, University of São Paulo, Ribeirão Preto-SP, Brazil. · Department of Neurosciences and Behavioral Sciences, Ribeirão Preto Medicine School, University of São Paulo, Ribeirão Preto-SP, Brazil. · Migraine & Headache Clinical Development, Global Branded R&D, Frazer, Pennsylvania. · Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, Alcorcón, Spain. · Pubmed 28390711
  • Albert Einstein Hospital, R Joaquim Eugenio de Lima, 881 cj 709, 01403-001, São Paulo, SP, Brazil. · Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Albert Einstein Hospital, R Joaquim Eugenio de Lima, 881 cj 709, 01403-001, São Paulo, SP, Brazil. · Natura, São Paulo, Brazil. · Teva Pharmaceuticals, North Wales, PA, USA. · Pubmed 28324317
  • Department of Biomechanics, Medicine and Locomotor Apparatus Rehabilitation - Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto-SP, Brazil. · Department of Physical Medicine and Rehabilitation, Harvard Medical School, Charlestown, MA, USA. · Department of Neurosciences and Behavioral Sciences - Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto-SP, Brazil. · Research and Development Department, Teva Pharmaceuticals, Frazer, PA, USA. · Pubmed 27991667
  • Department of Dental Materials and Prosthodontics/Araraquara School of Dentistry, University Estadual Paulista - UNESP, Araraquara, Brazil. · Department of Oral Kinesiology, Academic Centre for Dentistry Amsterdam (ACTA), MOVE Research Institute Amsterdam, University of Amsterdam and VU University Amsterdam, Amsterdam, The Netherlands. · Global Clinical Development - Migraine and Headaches, Teva Pharmaceuticals, Frazer, PA, USA. · Pubmed 27748537
2016
  • Research and Development, Teva Pharmaceutical Industries, Netanya, Israel. · Research and Development, Teva Pharmaceutical Industries, West Chester, PA, USA. · Clinical Development, Teva Pharmaceutical Industries, Frazer, PA, USA. · Children's Health Center, Duke University Medical Center, Durham, NC, USA. · Patient Safety & Pharmacovigilance, Teva Pharmaceutical Industries, Petach Tikva, Israel. · Dallas Pediatric Neurology Associates, Dallas, TX, USA. · NuPathe Inc, Conshohocken, PA, USA. · Palm Beach Neurology - Premiere Research Institute, West Palm Beach, FL, USA. · Research and Development, Teva Pharmaceutical Industries, Netanya, Israel. · Pubmed 27474357
  • Ribeirao Preto Medical School, Department of Biomechanics, Medicine and Locomotor Aparattus Rehabilitation, University of São Paulo, Ribeirao Preto, SP, Brazil. Electronic address: · Physiotherapy School, University of Maranhao Center, Sao Luis, MA, Brazil. · Ribeirao Preto Medical School, Department of Biomechanics, Medicine and Locomotor Aparattus Rehabilitation, University of São Paulo, Ribeirao Preto, SP, Brazil. · Ribeirao Preto Medical School, Department of Neuroscience and Behavioral Sciences, University of São Paulo, Ribeirao Preto, SP, Brazil. · Global Clinical Development, Teva Pharmaceutical Industries, Frazer, PA. · Pubmed 26718237
2015
  • Vice President, Migraine & Headache Clinical Development, Teva Pharmaceuticals, Frazer, PA. · Department of Neurology, Albert Einstein College of Medicine, Bronx, NY. · Director of Preclinical Research, Labrys Biologics, Inc, San Mateo, CA. · Director-Emeritus, New England Center for Headache, Stamford, CT. · Clinical Professor of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Pubmed 25614243
  • Research and Development Department, Teva Pharmaceuticals, Frazer, PA, USA. Electronic address: · Department of Neurology, Mayo Clinic, Phoenix, AZ, USA. · The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Neurology, Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA. · Statistics Department, Teva Pharmaceuticals, Frazer, PA, USA. · Research and Scientific Affairs Department, Teva Pharmaceuticals, Frazer, PA, USA. · Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Headache Institute and St Luke's-Roosevelt Hospital Center, New York, NY, USA. · Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA. · Pubmed 26432182
  • Research and Development Department, Teva Pharmaceuticals, Frazer, PA, USA. Electronic address: · Department of Internal Medicine, Lund University Hospital, Lund, Sweden. · The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA. · Clinical Research, MedVadis Research, Boston, MA, USA. · Department of Neurology, Essen Headache Center, Essen, Germany. · Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. · Research and Scientific Affairs Department, Teva Pharmaceuticals, Frazer, PA, USA. · Statistics Department, Teva Pharmaceuticals, Frazer, PA, USA. · Department of Neurology, Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA. · Pubmed 26432181
  • Department of Biomechanics, Medicine and Locomotor Apparatus Rehabilitation - Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil. · Department of Neurosciences and Behavioral Sciences - Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto-SP, Brazil. · Migraine & Headache Clinical Development, Global Branded R&D, Frazer, PA, USA. · Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, Alcorcón, Spain. · Pubmed 26388193
  • Migraine and Headache Clinical Development, Teva Pharmaceuticals, Frazer, PA, USA. · Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA. · Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. · Headache Institute, St. Luke's-Roosevelt Hospital Center, New York, NY, USA. · NuPathe Inc., Conshohocken, PA, USA. · Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Jefferson Hospital for Neuroscience, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Pubmed 26178815
2014
2012
  • Head of the Merck Investigator Study Program, Scientific Engagement and Education, Office of the Chief Medical Officer-Merck, North Wales, PA, USA. · Pubmed 22573400
2011
  • Office of the Chief Medical Officer, Merck & Co., Inc, North Wales, PA 19454, USA. · Pubmed 21755137
  • Head of the Merck Investigator Studies Program, Scientific Education Group, Office of the Chief Medical Officer, Merck Inc., Upper Gwynedd, PA, USA. · Pubmed 21359435
  • Head of the Merck Investigator Study Program and Scientific Education Group, Office of the Chief Medical Officer, Merck & Co., Inc., 351 North Sumneytown Pike, North Wales, PA 19454, USA. · Pubmed 21243447
2010
  • Office of the Chief Medical Officer-Merck inc. Upper Gwynedd, PA, USA. · Pubmed 20572878
  • Office of the Chief Medical Officer, Merck, 351 North Sumneytown Pike, Upper Gwynedd, PA 19454, USA. · Pubmed 20533956
  • Merck Inc., Upper Gwynedd, PA 19454, USA. · Pubmed 20490743
2015
  • Migraine & Headache, Clinical Development, Global Branded R&D, Teva Pharmaceuticals, 41 Moores Road, Frazer, PA, 19355, USA. · Pubmed 25754596
2011
  • Epidemiology Department, Merck Sharp & Dohme Corp., North Wales, PA 19454, USA. · Pubmed 21198571
2009
  • Epidemiology Department, Merck Research Laboratories, 351 North Sumneytown Pike, North Wales, PA, USA. · Pubmed 19456878
  • Merck Research Laboratories, North Wales, PA 19454-1099, USA. · Pubmed 19222588
Miscellaneous cities in Wales
2017
  • Albert Einstein Hospital, R Joaquim Eugenio de Lima, 881 cj 709, 01403-001, São Paulo, SP, Brazil. · Institute of Psychiatry, University of São Paulo, São Paulo, Brazil. · Albert Einstein Hospital, R Joaquim Eugenio de Lima, 881 cj 709, 01403-001, São Paulo, SP, Brazil. · Natura, São Paulo, Brazil. · Teva Pharmaceuticals, North Wales, PA, USA. · Pubmed 28324317
2012
  • Head of the Merck Investigator Study Program, Scientific Engagement and Education, Office of the Chief Medical Officer-Merck, North Wales, PA, USA. · Pubmed 22573400
2011
  • Office of the Chief Medical Officer, Merck & Co., Inc, North Wales, PA 19454, USA. · Pubmed 21755137
  • Head of the Merck Investigator Study Program and Scientific Education Group, Office of the Chief Medical Officer, Merck & Co., Inc., 351 North Sumneytown Pike, North Wales, PA 19454, USA. · Pubmed 21243447
2011
  • Epidemiology Department, Merck Sharp & Dohme Corp., North Wales, PA 19454, USA. · Pubmed 21198571
2009
  • Epidemiology Department, Merck Research Laboratories, 351 North Sumneytown Pike, North Wales, PA, USA. · Pubmed 19456878
  • Merck Research Laboratories, North Wales, PA 19454-1099, USA. · Pubmed 19222588
Thomas Jefferson University
2017
  • From the Jefferson Headache Center, Thomas Jefferson University, Philadelphia (S.D.S.), and Teva Pharmaceuticals, Frazer (M.E.B., P.P.Y., T.B., M.G.-W., R.Y., Y.M., E.A.) - both in Pennsylvania · Mayo Clinic Arizona, Phoenix (D.W.D.) · and National Institute for Health Research-Wellcome Trust King's Clinical Research Facility, King's College London, London (P.J.G.). · Pubmed 29171818
2009
  • Thomas Jefferson University, Department of Neurology, Philadelphia, PA 19107, USA. · Pubmed 19719543
Unspecified
2017
  • Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Biomecânica, Medicina e Reabilitação do Aparelho Locomotor, Programa de Pós-Graduação em Reabilitação em Desempenho Funcional, Ribeirão Preto SP, Brasil. · Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Neurociências e Ciências do Comportamento, Ribeirão Preto SP, Brasil. · Desenvolvimento Global da Teva Pharmaceutical Industries Ltd.,Filadélfia, EUA. · Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Laboratório de Análises da Postura e Movimento Humano (LAPOMH), Ribeirão Preto SP, Brasil. · Pubmed 28355322
2016
  • From Teva Pharmaceuticals (M.E.B., E.A., P.S.L., Y.M.) · Mayo Clinic (D.W.D., J.H.V.P.), Phoenix, AZ · The Headache Center of Rio (A.V.K.) · American Headache Society (A.V.K.) · Dartmouth Medical School (S.J.T.), Hanover, NH · and NIHR-Wellcome Trust King's Clinical Research Facility (P.J.G.), King's College London, UK. · Pubmed 27281531
2015
  • Universidade de Ribeirão Preto, Ribeirão Preto, SP, Brazil. · Divisão de Neurologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil. · Migraine & Headache Clinical Development. · Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Ribeirão Preto, SP, Brazil. · Pubmed 26200053
Miscellaneous cities in USA
2016
  • Ribeirão Preto Medical School, University of São Paulo, Brazil. Electronic address: · Ribeirão Preto Medical School, University of São Paulo, Brazil. · Teva Pharmaceuticals, USA. · Bernstein Focus Neurotechnology (BFNT) Göttingen, Bernstein Center for Computational Neuroscience, University Medical Center Göttingen, Georg-August University, Germany. · Universidad Rey Juan Carlos, Spain. · Pubmed 27317975
2014
  • Chief Medical Officer, Labrys Biologics, Inc., PA, USA. · Pubmed 23943638
  • Departamento de Neurologia, Faculdades Integradas Padre Albino, CatanduvaSP, Brazil. · Labrys Biologics, San MateoCA, USA. · Departamento de Neurologia, Universidade Federal de Santa Catarina, Florianopolis, Brazil. · Pubmed 24637977
Yeshiva University
2015
  • Vice President, Migraine & Headache Clinical Development, Teva Pharmaceuticals, Frazer, PA. · Department of Neurology, Albert Einstein College of Medicine, Bronx, NY. · Director of Preclinical Research, Labrys Biologics, Inc, San Mateo, CA. · Director-Emeritus, New England Center for Headache, Stamford, CT. · Clinical Professor of Neurology, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Pubmed 25614243
  • Migraine and Headache Clinical Development, Teva Pharmaceuticals, Frazer, PA, USA. · Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine, Bronx, NY, USA. · Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. · Headache Institute, St. Luke's-Roosevelt Hospital Center, New York, NY, USA. · NuPathe Inc., Conshohocken, PA, USA. · Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Jefferson Hospital for Neuroscience, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. · Pubmed 26178815
2009
  • Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Pubmed 19623468
  • Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Pubmed 19470970
  • Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Pubmed 19558539
2008
  • Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Pubmed 18779513
  • Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA. · Pubmed 18451714
  • Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA. · Pubmed 18417025
  • Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Pubmed 18184280
  • Merck Research Laboratories and the Albert Einstein College of Medicine-Neurology, Bronx, New York, NY, USA. · Pubmed 19031499
  • Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Pubmed 18505983
2012
  • Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. · Pubmed 22413150
2009
  • Department of Neurology, Albert Einstein College of Medicine, New York, NY 10461, USA. · Pubmed 19239676
2008
  • Departments of Neurology & Epidemiology and Population Health, Albert Einstein College of Medicine, and The Montefiore Headache Center, Bronx, NY, USA. · Pubmed 18479422
Miscellaneous cities in California
2014
  • Labrys Biologics Inc, 1810 Gateway Drive, Suite 230, San Mateo, CA, USA, · Pubmed 24638916
  • Labrys Biologics, Inc.; San Mateo, CA USA. · Pubmed 24866108
2013
Miscellaneous cities in New Jersey
2010
  • 1 Merck Dr., PO Box 100, Whitehouse Station, NJ 08889-0100, USA. · Pubmed 20147658
  • Merck Research Laboratories, Whitehouse Station, NJ, USA. · Pubmed 20039953
2009
  • Merck Research Laboratories, Whitehouse Station, NJ, USA. · Pubmed 19820895
  • Merck Research Laboratory, Whitehouse Statoin, New Jersey 08889, United States. · Pubmed 19833063
  • Merck Research Laboratories, Whitehouse Station, NJ 08889, USA. · Pubmed 19586594
  • Merck Research Laboratories, Merck, Inc., Whitehouse Station, New Jersey, USA. · Pubmed 19381087
  • Merck Research Laboratories, 1 Merck Drive, Whitehouse Station, NJ 08889, USA. · Pubmed 19289218
  • Merck Research Laboratories, Merck, Inc., 1 Merck Drive, Whitehouse Station, NJ 08889, USA. · Pubmed 19232469
  • Global Director for Scientific Affairs-Neuroscience; Merck Research Laboratories, Whitehouse Station, NJ, USA. · Pubmed 19161562
  • Merck Research Laboratories, Whitehouse Station, NJ 08889, USA. · Pubmed 19402776
  • The Merck Research Laboratories, 1 Merck Drive, office WHS-3C26, Whitehouse Station, NJ 08889, USA. · Pubmed 19389137
  • Merck Research Laboratories, Whitehouse Station, NJ 08889, USA. · Pubmed 19222509
2008
  • Merck Research Laboratories, Whitehouse Station, NJ 08889, USA. · Pubmed 19029522
  • Global Director for Scientific Affairs, Merck Research Laboratories, Whitehouse Station, NJ 08889, USA. · Pubmed 18796271
  • Global Center for Scientific Affairs, Neuroscience, Merck Research Laboratories, Whitehouse Station, NJ, USA. · Pubmed 18808500
  • Merck Research Laboratories, 1 Merck Drive, Whitehouse Station, NJ 08889, USA. · Pubmed 18711108
2010
  • Merck & Co., Inc, Global Outcomes Research, Whitehouse Station, NJ, USA. · Pubmed 19817884
2009
  • Global Outcomes Research, Merck & Co., Inc., Whitehouse Station, NJ 08889, USA. · Pubmed 19161564
18 Other Locations Show
Yearly article counts 175877109172715
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.